• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750CM26A
Device Problem Failure to Align (2522)
Patient Problem Insufficient Information (4580)
Event Date 01/25/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is still ongoing.
 
Event Description
As reported by the field clinical specialist (fcs), during a transfemoral tavr procedure with a 26mm sapien 3 ultra resilia, the valve was noted to be a millimeter or two past the distal maker on the balloon during valve alignment.However, the operator decided to deploy.During deployment, the proximal end of the balloon flared the back portion of the valve during inflation resulting in the valve migrating to the distal portion of the balloon (valve had a cone shape).The team was able to snare the valve to hold it in place, and the valve was then partially deployed with a 10mm peripheral balloon.The commander delivery system was removed from the patient, and a new commander delivery system was nominally prepped with 23cc and used to fully deploy the valve.The patient was stable exiting the room.
 
Manufacturer Narrative
The returned device was visually inspected, and the following was observed: the balloon was returned fully unpleated.Functional testing of the device was performed, and the following was observed: locking/unlocking and fine adjustment was performed successfully with no issues.Imagery was provided by the site and revealed the following: thv not centered over valve alignment markers during thv positioning prior to inflation, and incomplete partial inflation of thv.A lot history review was performed and revealed no other complaints relating to the reported event were identified.The instructions for use/training manuals were reviewed for guidance/instruction involving the esheath and delivery system usage.Based on the review of the ifu/training manuals, no deficiencies were identified.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaint for valve not aligned between markers and deployed, was confirmed by review of provided imagery.As reported, 'the valve was noted to be a millimeter or two past he distal marker on the balloon during valve alignment.However, the operator decided to deploy.During deployment, the proximal end of the balloon flared the back portion of the valve during inflation resulting in the migrating to the distal portion of the balloon'.The instructions for use and training manuals instruct the user to 'ensure that the valve is correctly positioned between the valve alignment markers.' if the valve is not between the valve alignment markers as observed, it will not be oriented fully over the inflation balloon working length, leading to incomplete or asymmetrical deployment, as observed.As such, available information suggests that procedural factors (misaligned valve on inflation balloon, valve not aligned between markers and deployed) may have contributed to the complaint event.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key16423269
MDR Text Key310039592
Report Number2015691-2023-10996
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103207835
UDI-Public(01)00690103207835(17)240918(10)64609683
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750CM26A
Device Catalogue Number9750CM26A
Device Lot Number64609683
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-